Clinical Trial Update: A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung [Phase 2]

View source ↗

Summary

A Phase 2 single-arm trial evaluating the combination of atezolizumab with platinum-based chemotherapy and etoposide for advanced large-cell neuroendocrine carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Neuroendocrine Carcinoma of the Lung

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Large Cell Neuroendocrine Carcinoma of the Lung | Phase 2 | Status: ACTIVE_NOT_RECRUITING